We’re excited to announce that the third episode of our podcast, “Invent: Life Science”, are now available!
From Plastics to Partnerships – The Path to Sustainability in Biopharma
In this episode, host Stuart explores what the sustainability goals of Big Pharma mean for those organisations, and the companies that support them. With insights from Ryan Walker, Sustainability Program Leader at Cytiva, and Wenshu Xu, Drug Discovery Tools Team Lead at TTP, we review the progress made by the industry so far and some examples where innovative thinking has had an impact on operations. Topics include the challenge of tackling Scope 3 emissions, reducing the impact of single-use plastics, and how collaboration across the ecosystem is key to meeting ambitious sustainability targets.
Listen now.
About TTP’s Cell and Gene Therapy Expertise
Cell and gene therapies offer potential cures for some of the most devastating and challenging conditions of our time. With our cell and gene product development expertise, TTP is enabling leading companies to commercialize and realize the full potential of their innovative cell therapies. Find out more here.
About host Stuart Lowe
As Head of the Biotech, Cell and Gene team at TTP, Stuart is passionate about solving time, cost, scale and sustainability challenges in cutting-edge pharmaceutical development, so that more people get access to life-changing therapies, sooner. The work Stuart and his team do enables TTP’s clients to launch disruptive products and create bespoke solutions, opening up new markets.